back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-06-24 10:00 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+254,345 vol |
4,015,963 | |
| Filed 2019-01-28 Tx date 2019-01-25 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,129,318 vol |
3,761,618 | |
| Filed 2018-09-27 Tx date 2018-09-24 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,262,475 vol |
2,632,300 | |
| Filed 2018-01-31 Tx date 2018-01-30 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+326,000 vol |
1,369,825 | |
| Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,022,610 vol |
||
| Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,022,610 vol |
||
| Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+681,740 vol |
1,043,825 | |
| Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+168,277 vol |
362,085 | |
| Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+193,808 vol |
193,808 |